Back to results
US 12,637,676 B2Granted
Treatment of optic atrophy
AssigneePYC Therapeutics Limited
InventorsJanya Grainok, Ianthe Pitout, Sasiwimon Utama, Kim Rice
Life of this patent
Estimating the term…
Abstract
An isolated or purified antisense oligomer for modulating mRNA translation of the OPA1 gene transcript or part thereof which has a modified backbone structure and sequences with at least 75% sequence identity to the isolated or purified antisense oligomer.
Claims11
An antisense oligomer for increasing mRNA translation of the optic atrophy 1 (OPA1) gene transcript or part thereof which has a modified backbone structure and wherein the antisense oligomer comprises SEQ ID NO:
- 57.
Dependencies are inferred from the claim text.